{"id":9086,"date":"2024-02-22T16:11:00","date_gmt":"2024-02-22T15:11:00","guid":{"rendered":"https:\/\/oxceed.com\/?p=9086"},"modified":"2025-09-01T09:58:26","modified_gmt":"2025-09-01T07:58:26","slug":"effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma","status":"publish","type":"post","link":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/","title":{"rendered":"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

En koncernstruktur i tillv\u00e4xt och s\u00e4rskilda krav p\u00e5 den ekonomiska uppf\u00f6ljningen inneb\u00e4r en rad utmaningar. Tidsbesparing, \u00f6kad s\u00e4kerhet och flexibla rapporter \u00e4r tre f\u00f6rdelar som Jennie Sterning, ekonomichef p\u00e5 l\u00e4kemedelsbolaget EQL Pharma, ser med Oxceed.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u2013 Tillv\u00e4xten st\u00e4ller krav p\u00e5 att strukturera upp processer och fl\u00f6den s\u00e5 effektivt som m\u00f6jligt, s\u00e4ger ekonomichefen Jennie Sterning.<\/p>

EQL Pharma \u00e4r en b\u00f6rsnoterad nordisk koncern<\/a> i l\u00e4kemedelsbranschen med fokus p\u00e5 att tillhandah\u00e5lla generika- och speciall\u00e4kemedel till den nordiska marknaden.<\/p>

Tidigare satt Jennie Sterning flera timmar varje m\u00e5nad med manuell hantering av olika rapporter. Eftersom ekonomisystemet inte kunde presentera data p\u00e5 det s\u00e4tt som beh\u00f6vdes byggde hon egna rapporter i Excel. Att f\u00f6ra \u00f6ver r\u00e5data dit tog dock tid, och dessutom fanns alltid en risk att n\u00e5got blev fel.<\/p>

\u00ad\u2013 Jag ins\u00e5g hur mycket tid jag la p\u00e5 att ta fram underlag f\u00f6r rapportering till ledningen. Jag ville effektivisera och slippa administrationen<\/a>, ber\u00e4ttar Jennie Sterning.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Boka en demo och uppt\u00e4ck Oxceed fr\u00e5n insidan<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Se hur Oxceed kan hj\u00e4lpa dig att spara tid, minska risken f\u00f6r fel och ge dig v\u00e4rdefulla insikter om f\u00f6retagets ekonomi.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tBoka demo<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Integrerat med bokf\u00f6ringssystemet<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

EQL Pharma valde att testa Oxceed d\u00e5 det \u00e4r integrerat med det ekonomisystem som bolaget anv\u00e4nder.<\/a> Det inneb\u00e4r att all bokf\u00f6ringsinformation fl\u00f6dar rakt in i Oxceed.<\/p>

\u2013 Oxceed \u00e4r l\u00e4tt att anv\u00e4nda och f\u00f6r den som vill finns det f\u00e4rdiga mallar f\u00f6r rapportering. F\u00f6r oss var det dock avg\u00f6rande att det \u00e4r enkelt att utforma sina egna rapporter.<\/a> Standardrapportering \u00e4r inget f\u00f6r mig, jag vill kunna titta p\u00e5 de bitar och de nyckeltal som \u00e4r intressanta f\u00f6r oss, s\u00e4ger Jennie Sterning.<\/p>

Hon har idag ett femtontal mallar f\u00f6r rapporter som anv\u00e4nds m\u00e5nadsvis. Varje m\u00e5nad kan hon enkelt skicka visuellt presenterade rapporter till ledningen.<\/a> Varje rapport tar n\u00e5gra sekunder att generera \u2013 ist\u00e4llet f\u00f6r som tidigare timmar av exportering och \u00f6verf\u00f6ring av data till Excel.<\/p>

EQL Pharma har ocks\u00e5 f\u00e5tt hj\u00e4lp av Oxceed att utveckla de funktioner som koncernens rapporteringsprocess har kr\u00e4vt.<\/p>

\u2013 Oxceed har varit lyh\u00f6rda f\u00f6r v\u00e5ra behov, och det \u00e4r v\u00e4ldigt v\u00e4rdefullt i ett samarbete, konstaterar Jennie Sterning.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Minskar risken f\u00f6r fel i rapporteringen<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Jennie Sterning tre prim\u00e4ra vinster med Oxceed: tidsbesparingen, s\u00e4kerheten och flexibiliteten i att enkelt kunna bygga egna rapporter.<\/p>

\u2013 Jag sparar ungef\u00e4r en halvdag i m\u00e5naden med Oxceed. Och det \u00e4r bara jag, mina kollegor sparar tid de ocks\u00e5. Ju mer vi kan effektivisera, desto st\u00f6rre blir kostnadsbesparingen f\u00f6r f\u00f6retaget n\u00e4r vi inte beh\u00f6ver ta in mer personal.<\/p>

S\u00e4kerheten \u00e4r en minst lika viktig vinst. N\u00e4r den manuella handp\u00e5l\u00e4ggningen f\u00f6rsvinner minskar risken f\u00f6r fel v\u00e4sentligt.<\/p>

\u2013 Det finns m\u00e5nga delar d\u00e4r det kan bli fel n\u00e4r du g\u00f6r det manuellt, konstaterar Jennie Sterning.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Varf\u00f6r Oxceed? Lyssna p\u00e5 v\u00e5ra kunder.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Oxceed anv\u00e4nds av \u00f6ver 20 000 f\u00f6retag och 200 redovisningsbyr\u00e5er i Sverige. L\u00e4s fler kundcase och ta del av deras omd\u00f6men.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tL\u00e4s fler kundcase<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Ett rapporteringsverktyg att v\u00e4xa med<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Just nu ligger fokus f\u00f6r EQL Pharma och Jennie Sterning p\u00e5 koncernens h\u00f6ga tillv\u00e4xttakt.<\/a> Men planen \u00e4r att dra \u00e4nnu st\u00f6rre nytta av Oxceed fram\u00f6ver genom att koppla p\u00e5 fler delar.<\/p>

\u2013 Vi \u00e4r bara i b\u00f6rjan. Det finns mycket funktionalitet kvar att utnyttja. Vi \u00e4r i en expansiv fas och tar en process i taget. Men jag kommer definitivt att vidareutveckla hur vi anv\u00e4nder Oxceed, s\u00e4ger Jennie Sterning.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Vill du veta mer? <\/h3>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\"\" <\/span><\/a>\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t\t

Effektivare rapportering och uppf\u00f6ljning f\u00f6r logistikf\u00f6retaget Boxflow<\/a><\/h3>\t\t
\n\t\t\tL\u00e4s mer<\/span><\/a>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\"Sanna <\/span><\/a>\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t\t

Snabbv\u00e4xande koncernen Mindpark valde Oxceed f\u00f6r b\u00e4ttre ekonomisk \u00f6verblick<\/a><\/h3>\t\t
\n\t\t\tL\u00e4s mer<\/span><\/a>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\"\" <\/span><\/a>\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t\t

S\u00e5 anv\u00e4nder SIA Glass Oxceed f\u00f6r ekonomisk rapportering och uppf\u00f6ljning<\/a><\/h3>\t\t
\n\t\t\tL\u00e4s mer<\/span><\/a>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\"\" <\/span><\/a>\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t\t

Precont skapar unika rapporter som alla f\u00f6rst\u00e5r<\/a><\/h3>\t\t
\n\t\t\tL\u00e4s mer<\/span><\/a>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

En koncernstruktur i tillv\u00e4xt och s\u00e4rskilda krav p\u00e5 den ekonomiska uppf\u00f6ljningen inneb\u00e4r en rad utmaningar. Tidsbesparing, \u00f6kad s\u00e4kerhet och flexibla rapporter \u00e4r tre f\u00f6rdelar som Jennie Sterning, ekonomichef p\u00e5 l\u00e4kemedelsbolaget EQL Pharma, ser med Oxceed. \u2013 Tillv\u00e4xten st\u00e4ller krav p\u00e5 att strukturera upp processer och fl\u00f6den s\u00e5 effektivt som m\u00f6jligt, s\u00e4ger ekonomichefen Jennie Sterning. EQL […]<\/p>\n","protected":false},"author":2,"featured_media":18740,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_trash_the_other_posts":false,"editor_notices":[],"footnotes":""},"categories":[1372521,1372369],"tags":[1372412,1372485,1372371],"class_list":["post-9086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-foretag","category-kundcase","tag-koncern","tag-lakemedel","tag-rapportering"],"acf":[],"yoast_head":"\nEffektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma - Oxceed Norway<\/title>\n<meta name=\"description\" content=\"Effektiv rapportering \u00e4r avg\u00f6rande f\u00f6r tillv\u00e4xtbolaget EQL Pharma som anv\u00e4nder rapporteringsverktyget Oxceed.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma\" \/>\n<meta property=\"og:description\" content=\"Effektiv rapportering \u00e4r avg\u00f6rande f\u00f6r tillv\u00e4xtbolaget EQL Pharma som anv\u00e4nder Oxceed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxceed Norway\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-22T15:11:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-01T07:58:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oxceed.com\/no\/wp-content\/uploads\/sites\/23\/2021\/02\/Oxceed-kundcase-EQL-Pharma-banner.001.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Martin Ericson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Martin Ericson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/\"},\"author\":{\"name\":\"Martin Ericson\",\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/#\\\/schema\\\/person\\\/b3e874d2e6116d756ef2aecb506e8880\"},\"headline\":\"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma\",\"datePublished\":\"2024-02-22T15:11:00+00:00\",\"dateModified\":\"2025-09-01T07:58:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/\"},\"wordCount\":705,\"image\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oxceed.com\\\/no\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2021\\\/02\\\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg\",\"keywords\":[\"koncern\",\"l\u00e4kemedel\",\"rapportering\"],\"articleSection\":[\"F\u00f6retag\",\"Kundcase\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/\",\"url\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/\",\"name\":\"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma - Oxceed Norway\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oxceed.com\\\/no\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2021\\\/02\\\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg\",\"datePublished\":\"2024-02-22T15:11:00+00:00\",\"dateModified\":\"2025-09-01T07:58:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/#\\\/schema\\\/person\\\/b3e874d2e6116d756ef2aecb506e8880\"},\"description\":\"Effektiv rapportering \u00e4r avg\u00f6rande f\u00f6r tillv\u00e4xtbolaget EQL Pharma som anv\u00e4nder rapporteringsverktyget Oxceed.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/oxceed.com\\\/no\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2021\\\/02\\\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg\",\"contentUrl\":\"https:\\\/\\\/oxceed.com\\\/no\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2021\\\/02\\\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/kundcase\\\/foretag\\\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/oxceed.com\\\/no\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/#website\",\"url\":\"https:\\\/\\\/oxceed.com\\\/no\\\/\",\"name\":\"Oxceed Norway\",\"description\":\"Fatta b\u00e4ttre beslut med Oxceed\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oxceed.com\\\/no\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oxceed.com\\\/no\\\/#\\\/schema\\\/person\\\/b3e874d2e6116d756ef2aecb506e8880\",\"name\":\"Martin Ericson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/176e21de61385d9ffc7eefd75788ccd94753d7352703cc12f102b743159c03c2?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/176e21de61385d9ffc7eefd75788ccd94753d7352703cc12f102b743159c03c2?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/176e21de61385d9ffc7eefd75788ccd94753d7352703cc12f102b743159c03c2?s=96&d=identicon&r=g\",\"caption\":\"Martin Ericson\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma - Oxceed Norway","description":"Effektiv rapportering \u00e4r avg\u00f6rande f\u00f6r tillv\u00e4xtbolaget EQL Pharma som anv\u00e4nder rapporteringsverktyget Oxceed.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_GB","og_type":"article","og_title":"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma","og_description":"Effektiv rapportering \u00e4r avg\u00f6rande f\u00f6r tillv\u00e4xtbolaget EQL Pharma som anv\u00e4nder Oxceed.","og_url":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/","og_site_name":"Oxceed Norway","article_published_time":"2024-02-22T15:11:00+00:00","article_modified_time":"2025-09-01T07:58:26+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/oxceed.com\/no\/wp-content\/uploads\/sites\/23\/2021\/02\/Oxceed-kundcase-EQL-Pharma-banner.001.jpeg","type":"image\/jpeg"}],"author":"Martin Ericson","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Martin Ericson","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/#article","isPartOf":{"@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/"},"author":{"name":"Martin Ericson","@id":"https:\/\/oxceed.com\/no\/#\/schema\/person\/b3e874d2e6116d756ef2aecb506e8880"},"headline":"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma","datePublished":"2024-02-22T15:11:00+00:00","dateModified":"2025-09-01T07:58:26+00:00","mainEntityOfPage":{"@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/"},"wordCount":705,"image":{"@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/oxceed.com\/no\/wp-content\/uploads\/sites\/23\/2021\/02\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg","keywords":["koncern","l\u00e4kemedel","rapportering"],"articleSection":["F\u00f6retag","Kundcase"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/","url":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/","name":"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma - Oxceed Norway","isPartOf":{"@id":"https:\/\/oxceed.com\/no\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/#primaryimage"},"image":{"@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/oxceed.com\/no\/wp-content\/uploads\/sites\/23\/2021\/02\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg","datePublished":"2024-02-22T15:11:00+00:00","dateModified":"2025-09-01T07:58:26+00:00","author":{"@id":"https:\/\/oxceed.com\/no\/#\/schema\/person\/b3e874d2e6116d756ef2aecb506e8880"},"description":"Effektiv rapportering \u00e4r avg\u00f6rande f\u00f6r tillv\u00e4xtbolaget EQL Pharma som anv\u00e4nder rapporteringsverktyget Oxceed.","breadcrumb":{"@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/#primaryimage","url":"https:\/\/oxceed.com\/no\/wp-content\/uploads\/sites\/23\/2021\/02\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg","contentUrl":"https:\/\/oxceed.com\/no\/wp-content\/uploads\/sites\/23\/2021\/02\/oxceed-kundcase-EQL-Pharma-banner.001-1.jpeg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/oxceed.com\/no\/kundcase\/foretag\/effektiv-rapportering-viktigt-for-tillvaxtbolaget-eql-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/oxceed.com\/no\/"},{"@type":"ListItem","position":2,"name":"Effektiv rapportering viktigt f\u00f6r tillv\u00e4xtbolaget EQL Pharma"}]},{"@type":"WebSite","@id":"https:\/\/oxceed.com\/no\/#website","url":"https:\/\/oxceed.com\/no\/","name":"Oxceed Norway","description":"Fatta b\u00e4ttre beslut med Oxceed","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oxceed.com\/no\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/oxceed.com\/no\/#\/schema\/person\/b3e874d2e6116d756ef2aecb506e8880","name":"Martin Ericson","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/176e21de61385d9ffc7eefd75788ccd94753d7352703cc12f102b743159c03c2?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/176e21de61385d9ffc7eefd75788ccd94753d7352703cc12f102b743159c03c2?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/176e21de61385d9ffc7eefd75788ccd94753d7352703cc12f102b743159c03c2?s=96&d=identicon&r=g","caption":"Martin Ericson"}}]}},"_links":{"self":[{"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/posts\/9086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/comments?post=9086"}],"version-history":[{"count":46,"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/posts\/9086\/revisions"}],"predecessor-version":[{"id":33919,"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/posts\/9086\/revisions\/33919"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/media\/18740"}],"wp:attachment":[{"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/media?parent=9086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/categories?post=9086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oxceed.com\/no\/wp-json\/wp\/v2\/tags?post=9086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}